SEI Investments’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,133
| Closed | -$256K | – | 2560 |
|
|
2020
Q4 | $256K | Sell |
3,133
-102,958
| -97% | -$5.39M | ﹤0.01% | 2277 |
|
|
2020
Q3 | $4.79M | Sell |
106,091
-16,247
| -13% | -$679K | 0.01% | 889 |
|
|
2020
Q2 | $5.48M | Sell |
122,338
-5,450
| -4% | -$244K | 0.02% | 820 |
|
|
2020
Q1 | $4.86M | Sell |
127,788
-55
| -0% | -$2.53K | 0.02% | 773 |
|
|
2019
Q4 | $5.92M | Sell |
127,843
-3,388
| -3% | -$147K | 0.02% | 828 |
|
|
2019
Q3 | $5.35M | Buy |
131,231
+28,422
| +28% | +$1.23M | 0.01% | 910 |
|
|
2019
Q2 | $4.96M | Sell |
102,809
-71
| -0.1% | -$3.73K | 0.02% | 939 |
|
|
2019
Q1 | $6.45M | Buy |
102,880
+39,557
| +62% | +$2.72M | 0.02% | 777 |
|
|
2018
Q4 | $4.01M | Buy |
63,323
+14,908
| +31% | +$895K | 0.01% | 998 |
|
|
2018
Q3 | $3.12M | Sell |
48,415
-5,925
| -11% | -$331K | 0.01% | 1102 |
|
|
2018
Q2 | $2.45M | Buy |
54,340
+40,677
| +298% | +$1.62M | 0.01% | 1247 |
|
|
2018
Q1 | $424K | Buy |
13,663
+3,699
| +37% | +$122K | ﹤0.01% | 1663 |
|
|
2017
Q4 | $694K | Sell |
9,964
-48,681
| -83% | -$1.41M | ﹤0.01% | 1588 |
|
|
2017
Q3 | $4.29M | Buy |
58,645
+52,862
| +914% | +$1.83M | 0.02% | 950 |
|
|
2017
Q2 | $193K | Buy |
5,783
+4,096
| +243% | +$122K | ﹤0.01% | 1881 |
|
|
2017
Q1 | $49K | Buy |
1,687
+680
| +68% | +$16.8K | ﹤0.01% | 2129 |
|
|
2016
Q4 | $166K | Buy |
+1,007
| New | +$19.7K | ﹤0.01% | 1833 |
|
Other funds holding BEAT
SEI Investments's BEAT Position: Q1 2021 in Review
SEI Investments sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,133 shares — an estimated $256K sold.
SEI Investments first reported a position in BEAT in Q4 2016 and held it in 17 quarters. The position peaked at $6.45M in Q1 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- SEI Investments reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- SEI Investments sold 3,133 BioTelemetry, Inc. shares in Q1 2021, an estimated $256K.
- SEI Investments first reported a position in BioTelemetry, Inc. in Q4 2016 and held it in 17 quarters.
- SEI Investments's BioTelemetry, Inc. position peaked at $6.45M in Q1 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on SEI Investments's 13F filing for Q1 2021, filed 12 May 2021.